By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: OCI Confirms Q3 2025 USD 700 Million Extraordinary Cash Distribution
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > OCI Confirms Q3 2025 USD 700 Million Extraordinary Cash Distribution
OCI Confirms Q3 2025 USD 700 Million Extraordinary Cash Distribution
News

OCI Confirms Q3 2025 USD 700 Million Extraordinary Cash Distribution

Last updated: 05/08/2025 8:37 AM
Published: 05/08/2025
Share
SHARE

AMSTERDAM, Aug. 4, 2025 /PRNewswire/ — OCI Global (Euronext: OCI), (“OCI,” the “Company”) announces today that it will pay a USD 700 million distribution (USD 3.31 per share) on 5 September 2025 through a mix of capital repayment and extraordinary cash dividend. This distribution is pursuant to the resolutions adopted at OCI’s annual general meeting on 21 May and will follow the lapsing of the mandatory creditor opposition period on 13 August. The ex-dividend date is 18 August, and the record date is 19 August.

- Advertisement -

Of the USD 700 million distribution, a proportion will be made as a repayment of capital corresponding to the amount of OCI’s remaining fiscal reserve, to be determined using the appropriate exchange rate on 3 September. Shareholders that do not wish to receive a capital repayment can elect to receive an extraordinary cash dividend from the profit reserve instead. Shareholders that do not make a choice will participate in a portion of their distribution paid as a repayment of capital. The Company will make distributions in USD unless the relevant shareholder has opted for a distribution in EUR. The EUR equivalent amount for those shareholders that elect for payment in EUR will be determined using the appropriate exchange rate on 3 September. The shareholder election period will run from 20 August through 2 September.

- Advertisement -

This press release contains information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

- Advertisement -

About OCI Global
Learn more about OCI at www.oci-global.com. You can also follow OCI on LinkedIn.

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/oci-confirms-q3-2025-usd-700-million-extraordinary-cash-distribution-302520340.html

- Advertisement -
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Vantage to Exhibit at Money Expo Colombia 2025
Shoals Technologies Group Secures Key Initial Win with the ITC to Protect U.S. Energy Innovation
KuCoin Brings “Guided into the Future” to Life at Tomorrowland Winter, Connecting Music, Culture, and Trust
Questex’s IHIF Asia Delivers Record Deal-Making Activity as $280B in Capital Targets APAC Hotel Market
TAGGED:2025700cashconfirmsdistributionextraordinarymillionnewsociusd
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
HCLTech named as one of the World’s Most Ethical Companies by Ethisphere for third consecutive year
News

HCLTech named as one of the World’s Most Ethical Companies by Ethisphere for third consecutive year

19/03/2026
InCorp Advisory, an Ascentium Company, strengthens Digital & Cyber Risk Practice with acquisition of Ken & Co.
SUJN celebrates 25 years of sharing exceptional hospitality while positively impacting thousands of lives and protecting India’s biodiversity
Safex Chemicals India Ltd. Receives Frost & Sullivan’s 2025 Global Competitive Strategy Leadership Recognition for Excellence in Crop Protection Chemicals
Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?